[Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion]

Claudio Bilato1, Alberto Zambon2, Livia Pisciotta3

  • 1Dipartimento Cardiovascolare, Azienda ULSS 8 Berica, Arzignano (VI).

Giornale Italiano Di Cardiologia (2006)
|December 27, 2022
PubMed

Insights

Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder causing dangerously high LDL cholesterol. Italian experts propose algorithms to help identify potential HoFH patients for early, specialized lipid-lowering therapy.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Context:

  • Homozygous familial hypercholesterolemia (HoFH) is a rare genetic condition.
  • Characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels.
  • Leads to premature atherosclerosis and severe cardiovascular events.

Purpose:

  • To provide practical guidance for identifying potential HoFH cases.
  • To facilitate early diagnosis and prompt initiation of lipid-lowering therapy.
  • To address the challenge of HoFH rarity in non-specialized centers.

Summary:

  • HoFH results from mutations in genes like LDLR, APOB, PCSK9, and LDLRAP1.
  • Untreated HoFH has a very high mortality rate, with fatalities recorded even in early childhood.
  • Italian experts developed three algorithms to aid in suspecting and identifying HoFH patients.
  • Suspected cases should be referred to specialized centers for optimal management.

Impact:

  • Early identification and treatment are crucial to prevent or delay cardiovascular complications.
  • The proposed algorithms aim to improve the detection rate of HoFH.
  • Facilitates timely referral to specialized centers for effective management of this rare disease.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
632
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
218
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
745